The paper emphasizes the potential of Lipella’s investigational therapy, LP-310, a novel oral rinse formulation of LP-10 (tacrolimus) specifically designed to provide localized therapeutic ...

There was also “strong” mechanistic evidence in exposed humans and human primary cells. Tacrolimus was classified as “carcinogenic to humans” (Group 1) based on “sufficient” evidence for cancer in ...

The structure of a market is described by the number of firms competing for the demand of consumers, the nature of costs, the extent of barriers to entry and also the bargaining power of consumers on ...